echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > 【One case per day】Long-term complications after brain radiotherapy: SMART syndrome

    【One case per day】Long-term complications after brain radiotherapy: SMART syndrome

    • Last Update: 2022-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, AJNR magazine published the following case report
    .
    The medical history is as follows:

    The patient, a 27-year-old man, was diagnosed with medulloblastoma at age 5 years and underwent hyperfractionated radiotherapy: 36 Gy of cerebrospinal cord radiation and adjuvant chemotherapy
    .
    The patient remained stable for 22 years, with migraine with loss
    of left visual field developed 1 week ago.

    Week1.
    Current MRI result (1A): FLAIR images show right parietal-temporal gyrus gyrus with abnormal FLAIR signaling and dural thickening
    .
    MRI (1B) from a year ago showed no cortical signal abnormalities and swelling, with mild dural thickening
    .

    Week2.
    Contrast enhancement level T1WI(2A) shows increased signal in the right temporal cortex swelling area, which does not exclude associated adjacent leptomeningeal enhancement, as no enhancement
    was seen on MRI T1WI(2B) a year ago.

    Week3.
    The horizontal DWI and corresponding ADC plots showed no diffusion restrictions and there was no sinus thrombosis
    .

    Week4.
    Follow-up FLAIR MRI (4A) and contrast enhancement level T1WI(4B) after 6 weeks showed no swelling, signal abnormalities, or enhancement
    .

    SMART syndrome

    SMART: Stroke-like migraine attack
    after radiation therapy.

    1.
    Reversible, recurrent, long-term complications after radiotherapy for brain tumors (average interval of 20 years);

    2.
    Complex migraine with neurological deficit and early seizures;

    3.
    The cause is unknown; May be associated with metabolic, neurological, endothelial injury/dysfunction, vascular instability, and vasospasm; In most cases, symptoms resolve after a few weeks, and symptoms rarely persist and high recurrence
    .

    The main diagnostic basis is:

    1.
    MR no positive findings (detected 2 to 7 days after symptom onset and disappears after a few weeks);

    2.
    Typical in the temporoparietal occipital lobe: transient unilateral gyrus-like T2 abnormal signal, FLAIR signal with mild mass effect, minimal leptomeningeal cortex enhancement signal;

    3.
    Cortical necrosis
    occurs in some cases.

    Differential diagnosis:

    Recurrence of tumors; prolonged seizures; Subacute cerebral infarction; Venous thrombosis; Radiation causes vascular lesions; Persistent complex migraine; hemiplegic migraine; Reversible posterior encephalopathy syndrome (PRES); mitochondrial encephalomyopathy, lactic acidosis, similar to a stroke attack (MELAS); Meningoencephalitis; Vasculitis; Cerebral autosomal dominant arterial disease is divided into cortical infarction and white matter disease (CADASIL).

    Treatment: antiepileptic drugs
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.